Education
About Us
Working with TipRanks
Follow Us
Aviva plc (GB:AV)
LSE:AV
Top Page
Aviva plc
(LSE:AV)
Select Model
Select Model
Rating:60Neutral
Price Target:
660.00 p
▲(6.52% Upside)
Action:DowngradedDate:03/07/26
The score is held back mainly by financial quality concerns—most notably cash-flow volatility and low/variable margins—despite solid balance-sheet positioning. A strongly constructive earnings call (raised targets, capital returns, and operational momentum) and an attractive dividend provide meaningful support, while the technical setup remains weak with the stock trading below major moving averages.
Positive Factors
Scale & Diversified Revenues
Aviva's large customer base and sizable Wealth AUM create durable fee and premium revenue streams. Scale across GI, Wealth and Retirement reduces reliance on any single market, supports cross‑sell (7m multiproduct holders) and sustains growth momentum and distribution advantages over the next few years.
Solid Capital & Returns Framework
A ~180% solvency ratio and multi‑bn own funds generation provide a sizable capital buffer to absorb underwriting shocks and support strategic actions. The resumed buyback and progressive dividend policy reflect management confidence and a repeatable capital return framework that underpins shareholder returns sustainably.
Technology & Claims Transformation
High adoption of ML pricing and quantified claims savings indicate structural cost and pricing advantages. Persistent efficiency gains improve underwriting margins, reduce unit costs and support competitive pricing, making margin expansion more durable as AI and process changes scale across lines of business.
Negative Factors
Cash Flow Volatility
Large, year‑to‑year free cash flow swings reduce confidence in internally generated funding for dividends, buybacks and M&A. Persistent volatility forces greater reliance on capital markets or asset sales, complicates multi‑year planning and raises risk that capital returns or targets prove harder to sustain.
Underwriting Volatility
An underlying combined ratio near 97% signals thin underwriting margins and sensitivity to catastrophe or large losses. If large loss frequency or severity remains elevated, it will structurally pressure GI profitability, require higher pricing or capital, and limit sustainable margin improvement despite operational levers.
Direct Line Integration Execution Risk
Realising multi‑year synergies requires consistent execution and uses capital and management bandwidth. Delays or shortfalls would defer solvency and EPS benefits, increase integration costs, and could erode the anticipated return on acquisition, making projected capital and earnings uplift less certain.
Aviva plc (AV) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£18.88B
Dividend Yield6.03%
Average Volume (3M)6.64M
Price to Earnings (P/E)18.9
Beta (1Y)1.17
Revenue Growth-19.71%
EPS Growth-53.86%
CountryUK
Employees29,091
SectorFinancial
Sector Strength70
IndustryInsurance - Diversified
Share Statistics
EPS (TTM)0.27
Shares Outstanding3,057,557,100
10 Day Avg. Volume6,511,212
30 Day Avg. Volume6,638,793
Financial Highlights & Ratios
PEG Ratio1.51
Price to Book (P/B)2.02
Price to Sales (P/S)0.33
P/FCF Ratio-6.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£725.08Price Target Upside17.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.6
Revenue Forecast (FY)£45.11B
Aviva plc Business Overview & Revenue Model
Company DescriptionAviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products. It also provides insurance cover to individuals, small and medium-sized businesses for risks associated with motor vehicles and medical expenses, as well as property and liability, such as employers' and professional indemnity liabilities. In addition, the company provides investment management services for institutional pension fund mandates; and manages various retail investment products, including investment funds, unit trusts, open-ended investment companies, and individual savings accounts for third-party financial institutions, pension funds, public sector organizations, investment professionals, and private investors. It markets its products through a network of insurance brokers, as well as MyAviva platform. The company was formerly known as CGNU plc and changed its name to Aviva plc in July 2002. Aviva plc was founded in 1696 and is headquartered in London, the United Kingdom.
How the Company Makes MoneyAviva generates revenue primarily through its insurance and investment operations. The company earns money from premiums collected on life and general insurance policies, which are a significant portion of its revenue. Additionally, Aviva derives income from investment management fees related to the assets it manages on behalf of policyholders and institutional clients. The company also benefits from investment income generated from its portfolio of assets, which includes bonds, equities, and real estate. Key partnerships with financial advisors, distribution networks, and technology firms further enhance its reach and efficiency, contributing to its earnings. Furthermore, Aviva has been focusing on digital transformation and enhancing customer experience, which are expected to drive growth in its revenue streams.
Aviva plc Earnings Call Summary
Earnings Call Date:Mar 05, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Aug 06, 2026
Earnings Call Sentiment Positive
The call presents a strongly positive operational and financial performance: Aviva beat near-term targets, delivered solid growth across GI, Wealth and Retirement, improved margins in many areas, and resumed capital returns (dividend and buyback). Technology and AI progress and Direct Line integration show strategic momentum. Balanced against these positives are near-term integration work for Direct Line, elevated underlying combined ratio driven by some large losses and one-off favourable items, and pockets of lower sales (protection) and IFRS dynamics in Retirement. Overall, the achievements and growth trajectory materially outweigh the challenges noted, leaving management confident in delivery of raised 3-year ambitions.Q4-2025 Updates
Positive Updates
Strong Group Financial Performance
Operating profit up 25% to GBP 2.2bn; operating EPS 56p; IFRS return on equity 17.5%; cash remittances up 4% to GBP 2.1bn; own funds generation (OFG) of c. GBP 2.3bn and solvency at c.180%.
Delivered 2026 Targets Early and Raised Ambitions
Management confirmed achievement of previously set 2026 group targets a year early, announced new 3-year targets (including Direct Line) and guidance for an 11% operating EPS CAGR to ~75p by 2028.
Customer and Scale Metrics
Over 25 million customers globally with >7 million multiproduct holders; Wealth assets > GBP 230bn; Workplace AUM GBP 153bn; record Wealth net flows of almost GBP 11bn.
General Insurance Growth and Improving Profitability
GI premiums up (Amanda cited +18% group GI; Charlotte: U.K. & Ireland premiums +27% including Direct Line; Commercial Lines premiums +7%); U.K. combined ratio 93.9% (1 point improvement) and GI operating profit expanded to almost GBP 1.5bn.
Wealth Momentum and Margin Expansion
Wealth operating profit up 36%; operating margin and operating profit as portion of revenue improved (operating margin progression noted; Workplace profit margin up ~2 percentage points over 2 years); Direct business customers grew ~33% to >100k.
Retirement Execution and Attractive Returns
Written GBP 4.6bn of bulk annuities in 2025 with Aviva Investors originating GBP 3.5bn of real assets to support transactions; achieved mid-teens IRR, above low‑teens guidance; individual annuity sales up 19% to GBP 1.6bn.
Shareholder Returns and Capital Actions
Final dividend 26.2p (total 39.3p) up 10% YoY; resumed share buyback at GBP 350m; clear capital allocation framework and target to deliver GBP 350m (7 points) solvency benefit from Direct Line synergies.
Direct Line Integration Progress
6-month contribution included in results; transferred GBP 2.9bn of assets to Aviva Investors; Direct Line branded PCW sales doubled in Q3 and nearly doubled again in Q4; delivered Direct Line's GBP 100m own cost programme and first GBP 50m of integration cost savings in H2 2025.
AI and Technology Gains with Measurable Benefits
Extensive ML pricing (98% of retail U.K. Personal Lines priced with ML); halved medical underwriting review time; reduced call wrap times by 20% in Direct Wealth; nearly GBP 100m saved via claims transformation; partnership announced with OpenAI.
Negative Updates
Underlying Combined Ratio and Large Losses
Group combined ratio reported 94.6% with an elevated underlying combined ratio (~96.7% per management commentary). Commercial Lines experienced elevated large losses in 2025 (idiosyncratic), and storm Eowyn impacted combined ratio for the year.
Direct Line Integration and Near-term Drag
Direct Line not yet at desired performance levels in H2 2025; integration used material capital (previously 31 points) and requires delivery of remaining cost synergies (remaining ~GBP 175m to be delivered over next 3 years) and at least GBP 350m/7 points solvency benefit to be realized.
One-off and Weather-Dependent Benefits
Management noted OFG and solvency benefits included some favorable weather and reinsurance pricing impacts that are one-offs and cannot be assumed to repeat, creating uncertainty around near-term comparability.
Protection Sales and Life/New Business Dynamics
Protection sales were lower following consolidation of AIG/Aviva propositions; Life / VNB metrics and Retirement operating profit showed pressures (Retirement operating profit down ~5% due to lower investment result despite higher CSM releases), and some IFRS17 mix effects reduced new-business-related metrics.
Reserve Strengthening and Elevated Current-Year Losses
Management disclosed reserve strengthening in parts of the portfolio and elevated current-year large losses which partially offset positive prior-year development and contributed to volatility in combined ratios.
Competitive Pressure and Market Cyclicality
UK is described as the most competitive market globally; management acknowledges the market remains cyclical and competitive pressures could constrain sustainable margin improvement despite AI and scale advantages.
Company Guidance
The management reiterated that 2025 met or beat prior guidance (operating profit +25% to £2.2bn; EPS 56p; IFRS ROE 17.5%; cash remittances +4% to £2.1bn; solvency 180%; OFG c.£2.3bn) and set new 3‑year targets including an 11% operating EPS CAGR from a 55p baseline to ~75p by 2028; near‑term operational guidance includes a U.K. & Ireland combined ratio of better than 94% in 2026 (Canada approaching 94%), at least £350m (c.7 solvency points) of Direct Line capital benefit to be delivered around year‑end, and an expected progressive operating capital generation of c.20 solvency points in 2027 (translating to ~2–4 solvency points depending on treatment). Capital return and cost plans were also guided: a final dividend 26.2p (total 39.3p, +10% y/y), a resumed share buyback of £350m, Direct Line cost‑saving ambition uplifted to £225m (first £50m delivered in H2 2025; remaining ~£175m phased over the next three years), ~£50m of investment to unlock at least £50m p.a. of claims savings, and continued growth ambitions in Wealth and Retirement (I.e. c.£230bn AUM, ~£11bn net flows, Workplace AUM £153bn and a Mercer transfer ~£8bn).Aviva plc Financial Statement Overview
Summary
Strong revenue growth and a generally manageable leverage profile are positives, but thin/uneven profitability and especially highly volatile cash generation (FCF swinging to materially negative in 2025 after a very strong 2024) materially weaken overall financial quality.Income Statement
Revenue expanded sharply in 2025 (up ~86% year over year), showing strong top-line momentum. However, profitability remains thin and somewhat volatile: net profit margin is low (~1.8% in 2025 vs. ~3.3% in 2023), and 2022 showed a net loss despite positive operating profit metrics. Overall, the company is growing, but earnings quality and consistency are mixed for the period provided.62
Positive
Balance Sheet
Leverage appears manageable for an insurer, with debt-to-equity broadly stable around ~0.7–0.9 in recent years (2025 ~0.86). Equity has grown from 2024 to 2025, and returns on equity improved to ~10.7% in 2025 (from ~8.2% in 2024), though it was negative in 2022. The balance sheet looks reasonably supported by equity, but the large asset base relative to equity and the history of ROE swings add risk.66
Positive
Cash Flow
Cash generation is the key weak spot: operating cash flow and free cash flow swung from strongly positive in 2024 (operating cash flow ~£8.4B; free cash flow ~£8.3B) to materially negative in 2025 (operating cash flow ~-£2.9B; free cash flow ~-£3.0B). Similar negative cash flow was also seen in 2023. This volatility reduces confidence in near-term funding flexibility and the reliability of internally generated cash.38
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 58.51B | 40.86B | 32.92B | -26.79B | 32.99B |
| Gross Profit | 58.51B | 31.76B | 33.95B | 16.20B | 32.99B |
| EBITDA | 2.56B | 1.58B | 2.03B | -887.00M | 1.33B |
| Net Income | 1.03B | 683.00M | 1.08B | -1.07B | 416.00M |
Balance Sheet | |||||
| Total Assets | 395.30B | 353.88B | 328.84B | 302.26B | 343.44B |
| Cash, Cash Equivalents and Short-Term Investments | 18.29B | 23.48B | 17.27B | 22.50B | 12.48B |
| Total Debt | 8.30B | 6.89B | 7.37B | 8.57B | 8.42B |
| Total Liabilities | 385.21B | 345.26B | 319.24B | 289.86B | 323.99B |
| Stockholders Equity | 9.69B | 8.30B | 8.79B | 12.09B | 19.20B |
Cash Flow | |||||
| Free Cash Flow | -2.96B | 8.27B | -3.08B | 3.85B | 3.19B |
| Operating Cash Flow | -2.87B | 8.45B | -2.73B | 3.95B | 3.30B |
| Investing Cash Flow | -1.14B | 162.00M | -350.00M | 11.13B | -6.58B |
| Financing Cash Flow | -1.73B | -2.49B | -1.82B | -5.47B | -3.91B |
Aviva plc Technical Analysis
Negative
619.60
Price Trends
647.19
Negative
655.16
Negative
648.60
Negative
Market Momentum
-4.29
Positive
41.55
Neutral
56.45
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:AV, the sentiment is Negative. The current price of 619.6 is below the 20-day moving average (MA) of 646.66, below the 50-day MA of 647.19, and below the 200-day MA of 648.60, indicating a bearish trend. The MACD of -4.29 indicates Positive momentum. The RSI at 41.55 is Neutral, neither overbought nor oversold. The STOCH value of 56.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:AV.
Aviva plc Risk Analysis
Aviva plc disclosed 15 risk factors in its most recent earnings report. Aviva plc reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Aviva plc Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | £26.85B | 9.78 | 25.01% | 1.56% | 37.94% | 291.37% | |
61 Neutral | £6.39B | 13.86 | 37.33% | 1.06% | -36.55% | ― | |
60 Neutral | £18.88B | 18.92 | 10.20% | 6.03% | -19.71% | -53.86% | |
52 Neutral | $6.61B | 22.80 | -1.53% | 7.09% | 9.86% | -134.41% | |
48 Neutral | £13.57B | 30.04 | 6.81% | 8.29% | -38.98% | -31.14% |
* Financial Sector Average
GB:AV
Aviva plc
619.60
101.23
19.53%
GB:LGEN
Legal & General
241.30
19.99
9.03%
GB:PRU
Prudential
1,068.00
286.11
36.59%
GB:STJ
St. James's Place
1,240.00
233.62
23.21%
GB:MNG
M&G Plc
278.80
89.17
47.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.